Managed care organizations (MCOs) integrate the financing and delivery of healthcare to control costs while maintaining quality. Unlike traditional indemnity insurance (which pays any provider any amount), MCOs use provider networks (selective contracting with physicians and hospitals at negotiated rates), gatekeeping (requiring primary care referrals for specialist access), utilization review (prior authorization, concurrent review, retrospective audit of clinical decisions), and financial incentives (capitation, risk-sharing) to manage the volume and cost of care. HMOs (Health Maintenance Organizations) use the tightest controls (closed networks, mandatory gatekeeping, capitation). PPOs (Preferred Provider Organizations) offer broader networks and direct specialist access at higher cost-sharing. The managed care revolution of the 1990s slowed US healthcare cost growth but generated a political backlash driven by perceived restrictions on patient choice and physician autonomy.
Traditional health insurance operates passively: the patient chooses any provider, receives any service the physician orders, and the insurer pays the bill. This arrangement maximizes patient choice and physician autonomy but provides no mechanism to control costs, evaluate necessity, or coordinate care. Managed care intervenes in all three areas, fundamentally changing the relationship between insurers, providers, and patients.
The core economic strategy of managed care is selective contracting. Instead of paying any willing provider, MCOs negotiate contracts with a limited network of providers at discounted rates. Hospitals and physicians accept lower per-unit prices in exchange for patient volume — being "in-network" channels the MCO's enrolled population toward them. Patients face higher cost-sharing or no coverage for out-of-network care, steering them toward contracted providers. This creates bargaining power that traditional insurance lacks: a large MCO can credibly threaten to exclude a hospital from its network, while individual patients cannot.
Utilization management is the second pillar. Prior authorization requires the insurer's approval before certain services (expensive imaging, elective surgery, specialty drugs) are delivered. Concurrent review monitors ongoing care (e.g., hospital length of stay) against evidence-based guidelines. Retrospective review audits claims after the fact to identify patterns of overutilization. These mechanisms directly intervene in clinical decision-making — the MCO's medical director or algorithms override or question the treating physician's judgment, which is the primary source of physician and patient dissatisfaction.
The HMO model represents the tightest integration: capitated payment to physicians, mandatory primary care gatekeeping, closed networks, and strong utilization review. The PPO model is looser: fee-for-service with negotiated discounts, no mandatory gatekeeper, and broader networks with graduated cost-sharing (lower for in-network, higher for out-of-network). The evolution from HMOs to PPOs over the 1990s and 2000s reflected the market's revealed preference: consumers were willing to pay higher premiums for greater choice and fewer restrictions. Current trends are moving back toward managed care principles under different labels — Accountable Care Organizations, narrow networks on ACA exchanges, and value-based contracts all use the same economic tools (selective contracting, utilization management, aligned incentives) in updated packaging.
No topics depend on this one yet.